fda行业指南委托生产质量协议中英文

上传人:第*** 文档编号:55571985 上传时间:2018-10-02 格式:PDF 页数:21 大小:687.84KB
返回 下载 相关 举报
fda行业指南委托生产质量协议中英文_第1页
第1页 / 共21页
fda行业指南委托生产质量协议中英文_第2页
第2页 / 共21页
fda行业指南委托生产质量协议中英文_第3页
第3页 / 共21页
fda行业指南委托生产质量协议中英文_第4页
第4页 / 共21页
fda行业指南委托生产质量协议中英文_第5页
第5页 / 共21页
点击查看更多>>
资源描述

《fda行业指南委托生产质量协议中英文》由会员分享,可在线阅读,更多相关《fda行业指南委托生产质量协议中英文(21页珍藏版)》请在金锄头文库上搜索。

1、FDA Guidance for Industry: Contract Manufacturing Arrangements for Drugs: Quality Agreements Page 1 / 21 FDA 行业指南:药品委托生产安排:质量协议 翻译:Julia Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry 行业行业指南:指南:药品药品委托委托生产生产安排安排:质量协议:质量协议 U.S. Department of Health and Human Se

2、rvices Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Veterinary Medicine (CVM) November 2016 Pharmaceutical Quality/Manufacturing Standards (CGMP) FDA Guidance for Industry: Contract Manufacturing Arrangemen

3、ts for Drugs: Quality Agreements Page 2 / 21 FDA 行业指南:药品委托生产安排:质量协议 翻译:Julia Guidance for Industry Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10001 New Hampshire Ave., Hillandale Bl

4、dg., 4th Floor Silver Spring, MD 20993-0002 Phone: 855-543-3784 or 301-796-3400; Fax: 301-431-6353 Email: druginfofda.hhs.gov http:/www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm and/or Office of Communication, Outreach and Development Center for Biologics Evaluation

5、 and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 71, Room 3128 Silver Spring, MD 20993-0002 Phone: 800-835-4709 or 240-402-8010 Email: ocodfda.hhs.gov http:/www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm and/or Policy and Re

6、gulations Staff, HFV-6 Center for Veterinary Medicine Food and Drug Administration 7519 Standish Place, Rockville, MD 20855 http:/www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/default.htm U.S. Department of Health and Human Services Food and Drug Administration Cente

7、r for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Veterinary Medicine (CVM) November 2016 Pharmaceutical Quality/Manufacturing Standards (CGMP) FDA Guidance for Industry: Contract Manufacturing Arrangements for Drugs: Quality Agreements Page 3 /

8、 21 FDA 行业指南:药品委托生产安排:质量协议 翻译:Julia TABLE OF CONTENTS 目录目录 TABLE OF CONTENTS 目录 3 I. INTRODUCTION 前言 . 4 II. DEFINING THE WHO AND WHAT OF CONTRACT MANUFACTURING 指定委托生产的人和事 6 III. RESPONSIBILITIES OF PARTIES INVOLVED IN CONTRACT MANUFACTURING 委托生产所涉及各方的职责7 IV. DOCUMENTING CGMP ACTIVITIES IN QUALITY A

9、GREEMENTS 在质量协议中记录 CGMP 活动 10 A. What Is a Quality Agreement? 什么是质量协议? . 10 B. Elements of a Quality Agreement 质量协议的要素 11 V. ILLUSTRATIVE SCENARIOS 案例 17 A. Owners and Contract Facilities Are Both Responsible for CGMP 所有者和受托场所是否都对CGMP负 责? 18 B. CGMPs Apply to all Contract Facilities, Including Analy

10、tical Testing Laboratories 适用于所有合同场所, 包括分析化验室的CGMP . 19 C. Owners and Contract Facilities Perform Change Control Activities 所有者和受托方实施变更控制活动20 VI. RECOMMENDATIONS 建议 21 FDA Guidance for Industry: Contract Manufacturing Arrangements for Drugs: Quality Agreements Page 4 / 21 FDA 行业指南:药品委托生产安排:质量协议 翻译:J

11、ulia Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry1 行业指南:药品行业指南:药品委托委托生产生产安排:安排:质量质量协议协议 This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is n

12、ot binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the FDA office responsible for this guidance as listed on the title page. 本指南代表 FDA当前对此问题的看法。它并未赋予任何人以任何权力,也不对

13、 FDA和公众具有任 何强制约束。如果你有一个替代的方法满足适用的法律法规要求,你可以使用该方法。如需对替代 方法进行讨论,请联系本指南标题页上的 FDA 官方负责人。 I. INTRODUCTION 前言前言 This guidance describes FDAs current thinking on defining, establishing, and documenting manufacturing activities of the parties involved in contract drug manufacturing subject to current good manufacturing practice (CGMP) requirements. In particular, we describe how parties involved in contract drug manufacturing can use quality agreements to d

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 办公文档 > 事务文书

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号